3 documents found, page 1 of 1
The Portuguese Society of Rheumatology position paper on the use of biosimilars...
Araújo, Filipe C.; Sepriano, Alexandre; Teixeira, F.; Jesus, D.; Rocha, T. M.; Martins, Paula Andreia; Tenazinha, C.; Cordeiro, A.; Mourão, A. F.Biosimilars are new and more affordable similar versions of previously approved reference biological drugs. Following the approval of the first monoclonal antibody biosimilar in 2013, the Portuguese Society of Rheumatology issued a position paper on the use of biosimilars in rheumatic conditions covering efficacy, safety, extrapolation, interchangeability, substitution and pharmacovigilance. However, as this is...
Portuguese recommendations for the prevention, diagnosis and management of prim...
Maria Rodrigues, Ana; Canhão, Helena; Marques, A.; Ambrosio, C.; Borges, J.; S. Coelho, Pedro; Costa, L.; Fernandes, S.; Goncalves, I; Goncalves, M. J.
The Portuguese Society of Rheumatology position paper on the use of biosimilars...
Araújo, F.C.; Sepriano, Alexandre; Teixeira, F.; Jesus, D.; Rocha, T.M.; Martins, P.; Tenazinha, C.; Cordeiro, A.; Mourão, A.F.; Silva, C.; Vaz, C.Biosimilars are new and more affordable similar versions of previously approved reference biological drugs. Following the approval of the first monoclonal antibody biosimilar in 2013, the Portuguese Society of Rheumatology issued a position paper on the use of biosimilars in rheumatic conditions covering efficacy, safety, extrapolation, interchangeability, substitution and pharmacovigilance. However, as this is...